Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Hepatocellular Carcinoma 1Stomatitis 1Respiratory Aspiration 1Recurrence 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Periodontitis 1Pain 1Ovariancancer 1Ovarian Neoplasms 1Non Small Cell Lung Caner 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myasthenia Gravis 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Calculi 1Immune Checkpoint Inhibitor-Induced Dermatitis 1Head and Neck Neoplasms 1Febrile Neutropenia 1Fatigue 1Dupuytren Contracture 1Depression 1

Interventions

Cisplatin 11toripalimab 8Capecitabine 8Gemcitabine 6Fluorouracil 5tislelizumab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3sintilimab 2anlotinib 2Taxes 2Radiation 2Drug Therapy 2spartalizumab 1pembrolizumab 1palbociclib 1nedaplatin 1lobaplatin 1camrelizumab 1Valganciclovir 1Therapeutics 1Taurine 1Sodium Fluoride 1Single Person 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leyk 1LY-2157299 1Induction Chemotherapy 1Docosahexaenoic Acids 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Carcinoma × Therapeutics × Clear all
NCT06781112 2025-01-17

A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

Chengdu University of Traditional Chinese Medicine

Phase 2 Not yet recruiting
35 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡